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Abstract
Pathogenic bacteria often damage tissues by secreting toxins that form pores in cell mem-
branes, and the most common pore-forming toxins are cholesterol-dependent cytolysins.
During bacterial infections, glutamine becomes a conditionally essential amino acid, and
glutamine is an important nutrient for immune cells. However, the role of glutamine in pro-
tecting tissue cells against pore-forming toxins is unclear. Here we tested the hypothesis
that glutamine supports the protection of tissue cells against the damage caused by choles-
terol-dependent cytolysins. Stromal and epithelial cells were sensitive to damage by the
cholesterol-dependent cytolysins, pyolysin and streptolysin O, as determined by leakage of
potassium and lactate dehydrogenase from cells, and reduced cell viability. However, gluta-
mine deprivation increased the leakage of lactate dehydrogenase and reduced the viability
of cells challenged with cholesterol-dependent cytolysins. Without glutamine, stromal cells
challenged with pyolysin leaked lactate dehydrogenase (control vs. pyolysin, 2.6 ± 0.6 vs.
34.4 ± 4.5 AU, n = 12), which was more than three-fold the leakage from cells supplied with
2 mM glutamine (control vs. pyolysin, 2.2 ± 0.3 vs. 9.4 ± 1.0 AU). Glutamine cytoprotection
did not depend on glutaminolysis, replenishing the Krebs cycle via succinate, changes in
cellular cholesterol, or regulators of cell metabolism (AMPK and mTOR). In conclusion,
although the mechanism remains elusive, we found that glutamine supports the protection
of tissue cells against the damage caused by cholesterol-dependent cytolysins from patho-
genic bacteria.
Introduction
Animals defend themselves against bacterial infections using the complimentary strategies of
resistance and tolerance [1–3]. Resistance is the ability to limit the pathogen burden, usually
by employing the immune system to kill bacteria. Tolerance is the ability to limit the severity
of disease caused by the pathogen burden, usually by limiting the damage caused by bacteria.
Bacteria often damage tissue cells by secreting toxins that form pores in the cell membrane,
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and the most common pore-forming toxins are cholesterol-dependent cytolysins [4–7]. Dur-
ing bacterial infections, the cells of the immune system use glutamine as a key nutrient to sup-
port inflammatory responses [8–10]. However, the role of glutamine in protecting tissue cells
against the damage caused by cholesterol-dependent cytolysins is unclear.
Cholesterol-dependent cytolysins include pyolysin secreted by Trueperella pyogenes, which
causes purulent infections in cattle and swine, such as postpartum uterine disease and abscesses,
and streptolysin O (SLO) secreted by beta-hemolytic group A Streptococci, which causes pharyn-
gitis and impetigo in children [11–14]. These cytolysins bind cholesterol-rich areas in tissue cell
membranes, where they form 30 nm diameter pores. The membrane pores lead to leakage of
potassium ions from cells within minutes, and further cell damage is evidenced by leakage of
proteins, such as lactate dehydrogenase (LDH), from the cytoplasm and ultimately cell death [6,
15]. Tissue cells try to protect themselves against the damage by activating stress responses and
transitioning to a quiescent metabolic state [5, 6]. However, the role of metabolism in protecting
cells against cholesterol-dependent cytolysins is unknown. An intriguing observation is that the
metabolic stress of lactation in dairy cattle increases the risk of postpartum uterine disease associ-
ated with T. pyogenes [16–19], probably by impairing the ability of the endometrial tissue to tol-
erate the presence of bacteria [20]. We therefore propose that the availability of nutrients might
affect the ability of tissue cells to protect themselves against cholesterol-dependent cytolysins.
Cells use glucose and glutamine to supply most of their energy [21–23]. The enzymes of the
glycolysis pathway convert glucose to pyruvate to feed the Krebs cycle, whilst glutaminase con-
verts glutamine to glutamate to replenish the Krebs cycle [9, 24]. Glutamine is an abundant
non-essential amino acid, with about 0.7 mM glutamine in human peripheral plasma and 0.25
mM in bovine plasma [8, 25]. However, glutamine becomes a conditionally essential amino
acid after injury or infection, and glutamine fosters immune cell inflammatory responses [8, 9,
26, 27]. As glutamine is a key nutrient, our aim was to test the hypothesis that glutamine sup-
ports the protection of tissue cells against the damage caused by cholesterol-dependent cytoly-
sins. To test our hypothesis we manipulated the supply of glutamine in the culture media and
examined the effects on cell viability and pore formation in both stromal and epithelial cells
that were challenged with pyolysin and streptolysin O.
Results
Pyolysin damages stromal cells
We isolated primary bovine endometrial stromal cells from uteri collected from cows after
slaughter, as described previously [14, 28, 29]. We used pyolysin to study cytoprotection
because bovine endometrial stromal cells are a principal target for pyolysin [14]; and, unlike
other cholesterol-dependent cytolysins, pyolysin does not require thiol-activation in vitro [13].
Pyolysin formed pores in the stromal cells, as determined by the loss of intracellular potassium
within 5 min (Fig 1A). Furthermore, a 2 h challenge with pyolysin damaged the stromal cells,
as determined by reduced cell viability (Fig 1B) and leakage of lactate dehydrogenase (LDH)
from the cytosol into cell supernatants (Fig 1C). We chose a 2 h pyolysin challenge based on
previous kinetic studies where 50% of endometrial stromal cells were perforated after 2 h [14].
Furthermore, the 2 h challenge reduces the likelihood of confounding cell protection with
immune responses to the cytolysins, which are usually evident in immune cells after 2 h of
challenge with cholesterol-dependent cytolysins [30].
Glutamine supports stromal cell protection against pyolysin
Primary bovine endometrial stromal cells are usually cultured in media containing 2 mM glu-
tamine [14, 28, 29], which is eight fold higher than the plasma concentration of glutamine in
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cows [25]. To examine if the availability of glutamine affected cytoprotection against pyolysin,
we cultured stromal cells for 24 h in serum-free media containing an excess of glucose (11.1
mM) with a range of concentrations of glutamine (0 to 2 mM), and then challenged the cells
for 2 h with control medium or 10 HU/well pyolysin. We used serum-free medium because
cholesterol in serum might bind cholesterol-dependent cytolysins, and to limit glutamine-
dependent differences in cell growth. Irrespective of glutamine availability, pyolysin caused
pore formation, as determined by loss of intracellular potassium within 5 min (Fig 2A; two-
way ANOVA, n = 3 animals, P< 0.001). We next evaluated the effect of glutamine on pyoly-
sin-induced cell damage by determining the leakage of LDH into cell supernatants. We did
not use the mitochondrial-dependent MTT assay for cell viability here because differences in
glutamine availability affect cell growth and mitochondrial function [8]. Furthermore, to
account for differences in cell growth, we measured cellular DNA at the end of each experi-
ment and normalized the leakage of LDH into cell supernatants using the cellular DNA in the
control challenge. Limiting the availability of glutamine increased the accumulation of LDH in
supernatants when cells were challenged with pyolysin (Fig 2B; two-way ANOVA; n = 4 ani-
mals, P< 0.001). The increased leakage of LDH in stromal cells cultured without glutamine,
compared with 2 mM glutamine, was evident from 15 min after pyolysin challenge (Fig 2C).
When cells were examined by light microscopy, cells cultured with 2 mM glutamine and
challenged with pyolysin showed some damage but usually maintained defined cell bound-
aries, whereas most cells were misshapen and the cytoplasm and nuclei condensed if they were
deprived of glutamine and challenged with pyolysin (Fig 2D). Staining the actin cytoskeleton
with Alexa Fluor 555-conjugated phalloidin also showed that when challenged with pyolysin
the cytoskeletal was more diffuse and disorganized, with less well defined actin fibers, and the
cell shape was more disrupted in cells deprived of glutamine than cells cultured with glutamine
(Fig 2E).
As primary cells often vary in their biological response, we verified our observation that glu-
tamine helped protect cells against pyolysin using stromal cells isolated from 12 independent
animals. The primary bovine endometrial stromal cells cultured without glutamine leaked
Fig 1. Cytolytic activity of pyolysin in stromal cells. (A) Primary bovine endometrial stromal cells were challenged for 5 min with control
serum-free medium (•) or medium containing pyolysin (�), and potassium was measured in cell lysates. Data are presented using cells isolated
from 3 animals and the horizontal line represents the mean; data were analyzed by t-test. (B, C) Stromal cells were challenged for 2 h with
control serum-free medium (∎) or medium with the indicated concentrations of pyolysin (∎); cell viability was determined by MTT assay (B)
and LDH leakage evaluated by measuring LDH in the cell supernatants (C). Data are presented as mean (SEM) using cells from 4 animals; data
were analyzed by ANOVA and P values are reported.
https://doi.org/10.1371/journal.pone.0219275.g001
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Fig 2. Glutamine is cytoprotective against pyolysin in stromal cells. (A) Bovine endometrial stromal cells were
cultured for 24 h in medium containing 2 mM glutamine or without glutamine, and challenged for 5 min with control
medium (•) or pyolysin (�). Intracellular potassium was determined by flame photometry. Data are from cells isolated
from 3 animals, with a horizontal line indicating the mean. (B) Cells were cultured in medium containing the indicated
concentrations of glutamine for 24 h, and challenged for 2 h with control medium (•) or 10 HU pyolysin (�), and LDH
measured in supernatants and normalized to cellular DNA in the control challenge. Data are mean (SEM) of cells
isolated from 4 animals, analyzed by ANOVA with Dunnett’s post hoc test; values differ from 2 mM glutamine
pyolysin challenge, ��� P< 0.001, � P< 0.05. (C) Stromal cells were cultured with 2 mM glutamine (Q, open symbols)
or without glutamine (0 mM Q, filled symbols) for 24 h, and challenged for the indicated times with control medium
or pyolysin; LDH leakage was measured in supernatants and normalized to cellular DNA in the control challenge. Data
are mean (SEM) of cells isolated from 4 animals; analyzed by ANOVA with Dunnett’s post hoc test; values differ from
2 mM glutamine pyolysin challenge, � P< 0.05. (D) Stromal cells were cultured with glutamine (2 mM Q) or without
glutamine (0 mM Q) for 24 h, and challenged for 2 h with control medium or pyolysin. Transmitted light micrographs
of cells were captured at the end of the experiment; right column represents magnification of boxed areas from middle
column; scale bar 10 μm; images are representative of cells from 4 animals. (E) Cells were also stained with Alexa Fluor
555-conjugated phalloidin to visualize F-actin (white) and fluorescent microscope images collected; nuclei are red;
scale bars are 20 μm; images are representative of cells from 4 animals. (F) Cells were cultured for 24 h in medium
containing 2 mM glutamine or without glutamine, and challenged for 2 h with control medium (∎) or 10 HU pyolysin
(∎), and LDH measured in supernatants and normalized to cellular DNA in the control challenge. Data are mean
(SEM) of cells isolated from 12 animals, analyzed by ANOVA with Bonferroni post hoc test; values differ from 2 mM
glutamine pyolysin challenge, ��� P<0.001.
https://doi.org/10.1371/journal.pone.0219275.g002
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more than three times the amount of LDH compared with cells cultured in medium contain-
ing 2 mM glutamine (Fig 2F).
We examined the possibility that glutamine deprivation might increase LDH leakage
because there was more intracellular LDH, if glutamine-deprived cells used lactate as an alter-
native metabolic substrate to glutamine. However, LDH activity in cell lysates was similar after
24 h culture of cells with or without glutamine (Fig 3A; independent t-test, P = 0.65, n = 4 ani-
mals). To test the possibility that glutamine might bind to pyolysin or neutralize the activity of
pyolysin, we used horse red blood cells, which are highly sensitive to hemolysis caused by cho-
lesterol-dependent cytolysins [14]. However, incubating glutamine with pyolysin did not affect
hemolysis, whereas incubating pyolysin with cholesterol, as a control, reduced hemolysis, as
expected for a cholesterol-dependent cytolysin (Fig 3B).
Alanine is an abundant non-essential amino acid in blood, and glutamine metabolism can
also yield alanine [21, 31]. Therefore, we considered if alanine might mimic the cytoprotective
effect of glutamine. Using glutamine-free medium, we cultured bovine endometrial stromal
cells with or without 2 mM alanine for 24 h prior to challenge with a range of concentrations
of pyolysin. However, supplying alanine did not significantly protect the cells from the leakage
of LDH after a 2 h challenge with PLO, compared with cells cultured without alanine (Fig 3D).
As supplying glutamine prior to pyolysin challenge supported cytoprotection, we wondered
whether glutamine could also help cells recover after pyolysin challenge. Cells were cultured
for 24 h in the presence or absence of 2 mM glutamine and then challenged for 2 h with pyoly-
sin, after which the media were replenished with or without 2 mM glutamine for a further 24
h. Cellular DNA was measured at the end of the experiment to estimate cell survival. Cells
treated with glutamine prior to pyolysin challenge showed no significant difference (P = 0.18)
in cellular DNA remaining when media were replenished with glutamine or not after pyolysin
challenge (Fig 3C, 2–2 and 2–0), with cell survival reduced by 26% and 33%, respectively.
However, deprivation of glutamine prior to pyolysin challenge, irrespective of whether media
were replenished with glutamine or not after pyolysin challenge, reduced cell survival by 70%
and 88%, respectively (Fig 3C, 0–2 and 0–0, P< 0.001). These data provide evidence that glu-
tamine supported cytoprotection against a pyolysin challenge, but glutamine did not help
recovery after a pyolysin challenge.
Glutamine supports stromal cell protection against streptolysin O
We next examined whether glutamine affected stromal cytoprotection against another choles-
terol-dependent cytolysin, streptolysin O (SLO). We first determined that a 2 h challenge with
SLO caused cell damage to bovine endometrial stromal cells, as determined by reduced cell
viability and leakage of LDH (Fig 4A and 4B). However, limiting the availability of glutamine
increased the leakage of LDH into cell supernatants when cells were challenged with SLO (Fig
4C; two-way ANOVA; n = 4 animals, P< 0.001). Together the data from Figs 2 to 4 provide
evidence that glutamine supports stromal cell protection against cholesterol-dependent
cytolysins.
Glutamine supports HeLa cell protection against pyolysin and streptolysin
O
We next examined whether glutamine cytoprotection against cholesterol-dependent cytolysins
was restricted to bovine endometrial stromal cells. We used immortalized human cervical epi-
thelial cells, HeLa cells, because they are widely employed to examine tissue cell responses to
cholesterol-dependent cytolysins [6, 32, 33]. First, we established that challenging HeLa cells
with pyolysin caused pore-formation, as determined by a reduction in intracellular potassium
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after 5 min (Fig 5A), a reduction in cell viability after 2 h (Fig 5B), and an increase in the leak-
age of LDH from the cytosol into cell supernatants (Fig 5C).
To examine if the availability of glutamine affected the protection of HeLa cells against pyo-
lysin, HeLa cells were cultured for 24 h in serum-free media containing excess glucose (25
mM) with a range of concentrations of glutamine (0 to 2 mM), and then challenged for 2 h
with control medium or 10 HU/well pyolysin. Irrespective of glutamine availability, pyolysin
caused pore formation, as determined by loss of intracellular potassium within 5 min (Fig 6A;
two-way ANOVA, P< 0.001). However, limiting the availability of glutamine increased the
accumulation of LDH in supernatants when HeLa cells were challenge with pyolysin (Fig 6B;
two-way ANOVA, P< 0.001). HeLa cells are also sensitive to SLO [33, 34], and we found that
glutamine deprivation also increased LDH leakage when HeLa cells were challenges with SLO
(Fig 6C; two-way ANOVA, P< 0.001). Staining actin with Alexa Fluor 555-conjugated
Fig 3. Glutamine is cytoprotective against pyolysin in stromal cells but does not alter intracellular LDH or bind
pyolysin. (A) Whole cell lysates were collected after 24 h treatment with 2 mM or no glutamine, and intracellular LDH
abundance measured, and normalized to cellular DNA. Data are mean (SEM) of cells isolated from 4 animals. (B) Red
blood cells were challenged with serial dilutions of pyolysin, after a prior 1 h incubation of the pyolysin with vehicle
(�), 2 mM glutamine (∎), or 1 μM cholesterol (◆). Hemolysis data are presented as mean of 2 experiments, with 2
replicates per treatment. (C) Bovine endometrial stromal cells were treated in glutamine-free medium containing no
alanine (�) or 2 mM alanine (�) for 24 h prior to challenge with control vehicle (0) or the indicated concentrations of
pyolysin, and the leakage of LDH from cells was measured in cell supernatants and normalized to cellular DNA in
control vehicle. Data are presented as mean (SEM) from 4 animals. (D) Cells were cultured in serum-free medium
containing 2 mM glutamine (2) or without glutamine (0) for 24 h before challenge with control medium (∎) or
pyolysin (∎) for 2 h. The media were then replenished with medium containing 2 mM glutamine (2) or without
glutamine (0) for a further 24 h and cellular DNA measured. Data are mean (SEM) from cells isolated from 4 animals,
and analyzed by ANOVA and Bonferroni post hoc test; values differ from 2–2 within challenge group, � P< 0.05, ���
P< 0.001.
https://doi.org/10.1371/journal.pone.0219275.g003
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phalloidin also showed that HeLa cells cultured without glutamine and challenged with pyoly-
sin had a diffuse actin cytoskeleton, presence of vacuoles, and disruption of the cell boundaries
with membrane blebs. Whereas, when cells were cultured with glutamine and challenged with
pyolysin, even though they lost their angular shape, the cells usually maintained defined cell
boundaries (Fig 6D).
We further validated the cytoprotective effect of glutamine in HeLa cells by taking advan-
tage of similar growth curves for HeLa cells irrespective of the glutamine supply when cells
were cultured with 10% fetal bovine serum, as determined by MTT assay (S1 Fig). Cells cul-
tured with glutamine prior to pyolysin challenge were less sensitive to cytolysis than cells cul-
tured in 2 mM glutamine (Fig 6E; two-way ANOVA, P = 0.001).
Fig 4. Glutamine is cytoprotective against streptolysin O in stromal cells. Bovine endometrial stromal cells were challenged for 2 h
with control serum-free medium (∎) or medium containing the indicated concentrations of SLO (∎); cell viability was determined by
MTT assay (A) and LDH leakage measured in the cell supernatants (B). Data are presented as mean (SEM) using cells isolated from 4
animals; data were analyzed by ANOVA and P values reported. (C) Cells were cultured in medium containing the indicated
concentrations of glutamine for 24 h, and challenged for 2 h with control medium (•) or 10 HU SLO (�), and LDH measured in
supernatants and normalized to cellular DNA in the control challenge. Data are mean (SEM) of cells isolated from 4 animals, analyzed by
ANOVA with Dunnett’s post hoc test; values differ from 2 mM glutamine SLO challenge, � P< 0.05, �� P< 0.01, ��� P<0.001.
https://doi.org/10.1371/journal.pone.0219275.g004
Fig 5. Cytolytic activity of pyolysin in HeLa cells. (A) HeLa cells were challenged for 5 min with control serum-free medium (•) or medium
containing pyolysin (�), and potassium was measured in cell lysates. Data are presented using cells from 3 independent cell passages and the
horizontal line represents the mean; data were analyzed by t-test. (B, C) Cells were challenged for 2 h with control serum-free medium (∎) or
medium containing the indicated concentrations of pyolysin (∎); cell viability was determined by MTT assay and LDH leakage measured in the
cell supernatants. Data are presented as mean (SEM) using cells from 4 passages; data were analyzed by ANOVA and P values reported.
https://doi.org/10.1371/journal.pone.0219275.g005
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Fig 6. Glutamine is cytoprotective against pyolysin in HeLa cells. (A) HeLa cells were cultured for 24 h in medium containing 2 mM
glutamine or without glutamine, and challenged for 5 min with control medium (•) or pyolysin (�). Intracellular potassium was
determined by flame photometry. Data are from 3 independent passages, with the horizontal line indicating the mean. (B, C) Cells were
cultured in medium containing the indicated concentrations of glutamine for 24 h, and challenged for 2 h with control medium (•), 10
HU pyolysin (�) or 10 HU SLO (�), and LDH measured in supernatants and normalized to cellular DNA in the control challenge. Data
are mean (SEM) of 4 passages, analyzed by ANOVA with Dunnett’s post hoc test; values differ from 2 mM glutamine cytolysin
challenge, ��� P<0.001. (D) Cells were cultured for 24 h in the presence of 2 mM glutamine (2 mM Q) or without glutamine (0 mM Q)
PLOS ONE Glutamine cytoprotection against cytolysins
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One consideration was whether cytoprotection was specific to glutamine, or whether the
cytoprotective effect of glutamine could be mimicked using the glutamine derivative, gluta-
mate, which is another non-essential amino acid [21, 31]. Using glutamine-free medium, we
cultured HeLa cells with or without a range of concentrations of glutamate for 24 h prior to
challenge with pyolysin. Cellular DNA was measured at the end of the experiment to estimate
cell survival. Cells treated with glutamine prior to pyolysin challenge protected against cytoly-
sis compared with cells without glutamine or glutamate (Fig 6F; 68% vs 34% survival). How-
ever, supplying glutamate did not significantly alter the leakage of LDH after a 2 h challenge
with PLO, compared with cells cultured without glutamate (Fig 6F; 37% survival with 2 mM
glutamate). In summary, the data in Fig 6 provide evidence that glutamine supports HeLa cell
protection against cholesterol-dependent cytolysins.
Glutaminolysis was not essential for cytoprotection against pyolysin
One obvious potential mechanism for the glutamine cytoprotection against cholesterol-depen-
dent cytolysins is that glutamine could supply cellular energy—even though the cells were sup-
plied with excess glucose (11 mM for stroma, 25 mM for HeLa cells). First we showed that
glucose was used by the cells for energy because inhibiting glycolysis, using 2-deoxy-D-glucose
[9], markedly increased LDH leakage from stromal cells challenged with pyolysin, when cells
were supplied with 2 mM glutamine (Fig 7A).
To explore the importance of glutamine as an energy substrate for cytoprotection, we exam-
ined the role of glutaminolysis, whereby glutaminase converts glutamine to glutamate, which
is metabolized to succinate to replenish the Krebs cycle [9, 24]. To inhibit glutaminolysis we
used the inhibitor BPTES, a bis-thiadiazole that induces an inactive conformation of glutamin-
ase [35, 36], and DON, a non-standard amino acid 6-Diazo-5-oxo-L-norleucine that covalently
binds glutaminase [37, 38]. We postulated that inhibiting glutaminase in cells supplied with 2
mM glutamine would mimic glutamine deprivation, leading to increased leakage of LDH. As
before, in the absence of the glutaminase inhibitors, glutamine deprivation increased the leak-
age of LDH from cells challenged with pyolysin (Fig 6B and 6C). However, the leakage of LDH
after pyolysin challenge was not significantly increased in cells treated with BPTES (Fig 7B;
two-way ANOVA, P = 0.86) or DON (Fig 7C; two-way ANOVA, P = 0.52). In a complemen-
tary approach, we cultured cells with a range of concentrations of succinate, in glutamine-free
medium, to assess whether the beneficial effect of glutamine was by replenishing the Krebs
cycle, and to account for the GABA (gamma-aminobutyric acid) shunt converting glutamine
to succinate [9]. However, supplying succinate did not significantly reduce the leakage of LDH
from cells in glutamine-free medium (Fig 7D; two-way ANOVA, P = 0.99).
Cells regulate their energy homeostasis using AMP-activated protein kinase (AMPK),
which senses increased AMP:ATP ratios, and mammalian target of rapamycin (mTOR),
which integrates satiety signals from hormones, growth factors, and the abundance of amino
acids, including glutamine [39, 40]. As glutamine influences AMPK and mTOR signaling [39,
41], we considered whether AMPK and mTOR might affect the ability of glutamine to support
in serum-free media, and then challenged for 2 h with control medium or pyolysin. The cells were stained with Alexa Fluor
555-conjugated phalloidin to visualize F-actin (white) and fluorescent microscope images collected; nuclei are red; scale bars are 20 μm.
Images are representative of 3 experiments. (E) Cells were treated with medium, containing 10% fetal bovine serum, with glutamine (2
mM Q, �) or without glutamine (0 mM Q, �) for 24 h before challenge with the indicated concentrations of pyolysin. Cell viability was
determined by MTT assay and expressed as the percent of control. Data are mean (SEM) of 4 passages. (F) Cells were cultured in serum-
free medium with the indicated concentrations of glutamine or glutamate for 24 h before challenge with control medium (∎) or pyolysin
(∎) for 2 h and cellular DNA measured. Data are mean (SEM) from 6 independent passages, and analyzed by ANOVA and Bonferroni
post hoc test, ��� P<0.001.
https://doi.org/10.1371/journal.pone.0219275.g006
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cytoprotection against pyolysin. However, there was no substantive change in LDH leakage
from cells challenged with pyolysin when mimicking metabolic energy deficits by activating
Fig 7. Stromal cell metabolism and cytoprotection against pyolysin. Bovine endometrial stromal cells were cultured in serum-free
media for 24 h with the indicated concentrations of glutamine and the glycolysis inhibitor 2-deoxy-D-glucose (2DG; A), glutaminolysis
inhibitors BPTES (B) or DON (C), succinate (D), AMPK activator AICAR (E), or mTOR inhibitor rapamycin (F), and then challenged for
2 h with control medium (∎) or pyolysin (∎). The leakage of LDH from cells was measured in cell supernatants, and normalized to cellular
DNA in the control challenge. Data are presented as mean (SEM) using cells isolated from 4 animals for each experiment. Data were
analyzed by ANOVA and Dunnett’s post hoc test; the reported P values are the effect of the treatment on the response to pyolysin
challenge. ND, not detectable.
https://doi.org/10.1371/journal.pone.0219275.g007
Fig 8. Glutamine and cellular cholesterol. HeLa cells (A) and bovine endometrial stromal cells (B) were cultured for 24 h in serum-free media
with glutamine (2 mM Q), 0.5 mM methyl-β-cyclodextrin (MβCD), or without glutamine (0 mM Q). Cellular cholesterol was measured and
normalized to the phospholipid content to account for differences in cell growth. Data are presented using 4 independent cell passages for HeLa
cells or 4 animals for stromal cells; the horizontal line represents the mean. Data were analyzed by ANOVA and Dunnett’s post hoc test; values
differ from 2 mM glutamine, � P< 0.05, ��� P< 0.001. (C) Confocal microscope images of HeLa cells stained with filipin to visualize cholesterol
(white) for the indicated treatments; scale bars are 20 μm.
https://doi.org/10.1371/journal.pone.0219275.g008
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AMPK with AICAR (Fig 7E; ANOVA, P = 0.42) or inhibiting mTOR with rapamycin (Fig 6F:
ANOVA, P = 0.31). Together, the data in Fig 7 provide evidence that glutamine supports cyto-
protection against pyolysin but that this cytoprotection was not dependent on glutamine
replenishing the Krebs cycle.
Glutamine and cellular cholesterol
A second potential mechanism for glutamine cytoprotection against cholesterol-dependent
cytolysins is that glutamine could reduce cellular cholesterol. Methyl-β-cyclodextrin is widely
used to reduce cellular cholesterol [14, 32], and in the present study, treating cells with 0.5 mM
methyl-β-cyclodextrin for 24 h also reduced cellular cholesterol in HeLa cells (Fig 8A) and in
stromal cells (Fig 8B). This reduced cellular cholesterol also protected the cells against a 2 h
pyolysin challenge, as determined by MTT assay for HeLa cells (methyl-β-cyclodextrin vs.
vehicle, 96.6 ± 7.3 vs. 14.8 ± 0.5% viability of control; P < 0.001, t-test, n = 4) and stromal cells
(methyl-β-cyclodextrin vs. vehicle, 76.7 ± 13.4 vs. 11.8 ± 3.2% viability of control; P< 0.001, t-
test, n = 7). However, cholesterol concentrations did not significantly differ between cells cul-
tured with or without 2 mM glutamine for both HeLa cells (Fig 8A, P = 0.63) or endometrial
stromal cell (Fig 8B, P = 0.26). We also took advantage of the well-defined HeLa cell shape and
used filipin and confocal microscopy to examine the distribution of cholesterol [42]. HeLa
cells cultured with or without glutamine showed little difference in staining intensity (Fig 8C).
Taken together these data do not support the idea that glutamine could alter cytoprotection
against cholesterol-dependent cytolysins by modifying the abundance of cellular cholesterol.
Discussion
We found that glutamine supports the protection of tissue cells against the damage caused by
cholesterol-dependent cytolysins from pathogenic bacteria. The role of glutamine in cytopro-
tection was unexpected, but was consistent across a range of experiments. Glutamine sup-
ported cytoprotection against two different cholesterol-dependent cytolysins, pyolysin and
streptolysin O, in two disparate tissue cell types, primary bovine endometrial stromal cells and
immortalized human cervical epithelial cells.
Supplying glutamine reduced the damage that the cytolysins caused to the cells, even
though pores formed in the cell membrane, as evidenced by the rapid leakage of potassium
from cells. This glutamine cytoprotection was evident by examining cell viability, imaging
cells, and by measuring the leakage of LDH from cells. We chose a 2 h challenge with choles-
terol-dependent cytolysins to test cytoprotection, rather than a longer cytolysin challenge,
which might also reflect longer-term immune responses, or damage repair and recovery
responses [6, 30]. Finding that glutamine reduced pyolysin-induced cell death if given before,
but not after pyolysin challenge also supports a role for glutamine in protecting cells, rather
than damage repair. Glutamine was specifically required for cytoprotection as glutamate or
alanine did not mimic the cytoprotection against pyolysin provided by glutamine.
Infections are metabolically demanding [9, 25, 43]. We therefore considered whether cyto-
protection against cholesterol-dependent cytolysins might depend on glutamine replenishing
the Krebs cycle [9]. Glutaminase is active in fibroblasts and HeLa cells, converting glutamine
to glutamate, which is then used to yield succinate for the Krebs cycle [44, 45]. However, inhib-
itors of glutaminase did not impair cytoprotection against pyolysin in the present study. Fur-
thermore, supplying succinate to cells in glutamine-free media did not enhance
cytoprotection. Damage and infections also activate AMPK, and glutamine regulates AMPK
and mTORC1 signaling [39, 41], but manipulating AMPK or mTOR in the present study did
not affect cytoprotection against pyolysin. Taken together, these lines of evidence imply that
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whilst glutamine was important for cytoprotection against cholesterol-dependent cytolysins,
the mechanism did not depend on glutaminolysis. These findings are intriguing because
although immunity and tolerance complement each other, they can employ different mecha-
nisms [46–48]. Indeed, whilst succinate did not contribute to cytoprotection against cytolysins
here, cellular succinate regulates innate immunity and drives inflammatory responses to bacte-
rial lipopolysaccharide in macrophages [9, 10]. Furthermore, manipulating AMPK or mTOR,
as well as reducing the availability of glucose or glutamine, impairs inflammatory responses to
lipopolysaccharide in the bovine endometrium [49, 50].
Cholesterol is the binding target for pyolysin and SLO [5], and reducing cholesterol in the
cell membrane increases cytoprotection against cholesterol-dependent cytolysins [14, 33, 51].
However, in the present study, any effects of glutamine on cellular cholesterol abundance or
distribution were modest compared with methyl-β-cyclodextrin. These findings are plausible
because glutamine can provide citrate for cholesterol synthesis, and glutamine stimulates the
expression of genes associated with cholesterol synthesis [31, 52].
In the present in vitro studies, only 0.25 mM glutamine was needed to protect cells against
the cytolysins, and there is about 0.7 mM glutamine in human plasma and 0.25 mM in bovine
plasma [8, 25]. However, the glutamine available for cellular metabolism may be far less than
implied by the plasma concentrations of glutamine. The availability of glutamine also depends
on the rate of glutamine transporter-mediated influx and efflux, as well as glutamine synthesis
[53, 54]. Glutamine even becomes conditionally essential during injury or infection, and gluta-
mine supplementation is used therapeutically [8, 26, 27, 53]. Part of this increased demand for
glutamine is to fuel the repair of tissue damage and the synthesis of inflammatory mediators.
However, damage and inflammation may also limit the ability of glutamine to diffuse from
blood vessels into the tissues. Furthermore, pathogenic bacteria, such as Escherichia coli, Sal-
monella typhimurium and Streptococcus pneumoniae, can take up glutamine or synthesize glu-
tamine, and glutamine is important for their metabolism and virulence [55–57]. To explore
the integration of glutamine physiology between cells and bacteria, future studies could
manipulate the supply of glutamine to stromal and epithelial cells challenged with live T. pyo-
genes and beta-hemolytic group A Streptococci. However, this will be challenging as the mam-
malian cells and bacteria differ in their culture conditions in vitro. As glutamine has multiple
roles during infections, and contributes to amino acids, proteins, and nucleotides as well as
supplying the Krebs cycle, future studies might also use radiolabeled glutamine to trace how
glutamine contributes to cytoprotection and bacterial virulence.
Cell protective mechanisms against pore-forming toxins include changes in the plasma
membrane and membrane receptors, activation of cell stress responses, membrane repair, and
cytoskeletal maintenance [6, 7, 15, 30, 32, 34, 58]. Cell stress responses and membrane repair
in response to damage caused by cholesterol-dependent cytolysins has been studied widely,
but not explicitly linked to the supply of glutamine. An interesting feature noted in the present
study was that glutamine was important to limit toxin-induced changes in the actin cytoskele-
ton and plasma membrane, which might help cells tolerate damage, changes in osmotic pres-
sure, or the remodeling of actin during pore-formation [59]. Another aspect that might be
explored in the future is a link between glutamine and epidermal growth factor receptor func-
tion, which protects the gut barrier and tight junctions between epithelial cells against damage
caused by alcohol [60]. The beneficial role of glutamine in tissue cytoprotection complements
the role glutamine plays in immune cell metabolism and supporting inflammatory responses
to pathogens [9, 48]. However, it is unlikely that the glutamine cytoprotection was dependent
on cytokines released from cells during the experiments because bovine endometrial stromal
cells and peripheral blood mononuclear cells do not secrete interleukins in response to pyoly-
sin [14].
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In conclusion, we found that glutamine supports the protection of tissue cells against the
damage caused by cholesterol-dependent cytolysins from pathogenic bacteria. More work will
be needed to determine the mechanism linking glutamine to cytoprotection against cytolysins.
However, the implication of finding that glutamine supports cytoprotection is that glutamine
may help tissues to tolerate pathogenic bacteria that secrete cholesterol-dependent cytolysins.
Methods
Ethical statement
No live animal experiments were performed. Uteri were collected from cattle after slaughter
and processing, as part of the normal work of a commercial slaughterhouse, with approval
(registration number U1268379/ABP/OTHER) from the United Kingdom (UK) Department
for Environment, Food and Rural Affairs under the Animal By-products Registration (EC)
No. 1069/2009.
Cell culture
To isolate primary bovine endometrial stromal cells, uteri were collected after slaughter from
post pubertal, non-pregnant animals with no evidence of genital disease or microbial infection.
Endometrial stromal cells were isolated, cell purity confirmed, and the absence of immune cell
contamination verified, as described previously [14, 28, 29]. A standard operating procedure
details the isolation of these primary cells from bovine uteri [61]. Briefly, stromal cells were iso-
lated by enzymatic digestion of the endometrium, sieving the cell suspension through a 70-μm
mesh to remove debris, and then through a 40-μm mesh (pluriStrainer1, Cambridge Biosci-
ence, Cambridge, UK) to isolate stromal cells, followed by adhesion to culture plates within 18
h, at which time any contaminating epithelial cells were washed away. The cells were main-
tained in 75 cm2 flasks (Greiner Bio-One, Gloucester, UK) with complete medium, comprising
RPMI-1640 medium (Catalogue number #61870, Thermo Fisher Scientific, Paisley, UK), 10%
fetal bovine serum (Biosera, East Sussex, UK), 50 IU/ml of penicillin, 50 μg/ml of streptomycin
and 2.5 μg/ml of amphotericin B (all Sigma, Gillingham, UK). Cells were used from passage 1
and 2.
The immortal HeLa cells were purchased for the study (Public Health England, Salisbury,
UK; #93021013, HeLa CCL2), and cultured cells were maintained in 75 cm2 flasks with com-
plete medium, comprising DMEM (#41965, Thermo Fisher Scientific) 10% fetal bovine serum,
50 IU/ml penicillin, 50 μg/ml streptomycin, and 2.5 μg/ml amphotericin B. Cells were used
from passage 5 to 25. The HeLa cell identity was confirmed at the end of the study by short tan-
dem repeat profiling (Report Reference number SOJ39361; ATCC, Manassas, VA, USA). Cells
were incubated at 37˚C in humidified air with 5% CO2.
Cholesterol-dependent cytolysins
The plo plasmid (pGS59) was a gift from Dr H Jost (University of Arizona), and pyolysin pro-
tein was generated as described previously [14, 62]. The activity of pyolysin was 628,338 HU/
mg protein, as determined by hemolysis assay using horse red blood cells (Oxoid, Hampshire,
UK), as described previously [14, 63]. Endotoxin contamination was 1.5 EU/mg protein, as
determined by a limulus amebocyte lysate assay (LAL endotoxin quantitation kit; Thermo
Fisher Scientific, Hertfordshire, UK). Streptolysin O was purchased from Sigma, stored as 1
mg/ml solution, and activated with 10 mM dithiothreitol according to the manufacturer’s
instructions (Sigma). To examine the potential for pyolysin binding to glutamine, 100 HU/ml
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pyolysin was incubated for 1 h in PBS with vehicle, 2 mM glutamine, or 1 mM cholesterol as a
positive control, and a hemolysis assay was conducted.
Glutamine manipulation
The bovine endometrial stromal cells were seeded at 5 × 104 cells/well in 24-well plates and
incubated for 24 h in complete medium. The cells were then incubated for 24 h in serum-free
medium containing the amounts of L-glutamine specified in Results, which were generated by
combining defined ratios of RPMI1640 with or without L-glutamine (#11875, 11.1 mM glucose,
2 mM glutamine; and, #31870, 11.1 mM glucose, no glutamine; Thermo Fisher Scientific).
The HeLa cells were seeded at 4 × 104 cells/well in complete medium for 24 h, followed by a
further 24 h in serum-free medium containing the amounts of L-glutamine specified in
Results, which were generated by combining defined ratios of DMEM with or without L-gluta-
mine (#41965, 25 mM glucose, 4 mM glutamine; and, #11960, 25 mM glucose, no glutamine;
Thermo Fisher Scientific).
After the treatment period, cells were challenged with their corresponding control medium,
or medium containing pyolysin or SLO, as specified in Results. In some experiments, transmit-
ted light images of the cells were collected using an Axiovert 40C inverted microscope and
AxioCam ERc5s camera (Zeiss, Jena, Germany). At the end of experiments, cell supernatants
were collected for LDH quantification, and cells used for measuring cellular DNA or viability.
Nutrients and inhibitors
To examine the effect of nutrients, cells were seeded and cultured for 24 h in complete media,
and then cultured for 24 h in serum-free media containing the amounts reported in Results of
L-alanine (#05129, Sigma), glutamate (L-Glutamic acid monosodium salt hydrate, #G5889,
Sigma) or dimethyl succinate (#W239607, Sigma). After 24 h treatment, cells were challenged
for 2 h with pyolysin, and supernatants and cells collected. To examine the effect of inhibitors,
cells were seeded and cultured for 24 h in complete media, and then cultured for 24 h in
serum-free media containing the amounts reported in Results of the glycolysis inhibitor
2-deoxy-D-glucose (2DG; #D3179, Sigma), the glutaminase inhibitors BPTES (#314045, EMD
Millipore, Hertfordshire, UK) or DON (#D2141, Sigma), the AMPK activator AICAR (#2840,
Tocris, Bristol, UK), the mTOR inhibitor rapamycin (#553211, EMD Millipore), or methyl-β-
cyclodextrin (#332615, Sigma). After 24 h treatment, cells were challenged for 2 h with control
medium or pyolysin, and supernatants and cells collected.
Cell viability
The mitochondria-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT, Sigma) to formazan was used to assess cell viability, as described previ-
ously [14]. As nutrient availability may influence the reduction of MTT, cell abundance was
also determined by measuring cellular DNA content. Briefly, at the end of experiments when
supernatants were removed, the cells were washed in 500 μl ice-cold PBS before being stored
at -80˚C overnight to ensure lysis, and DNA was measured using the CyQUANT Cell Prolifer-
ation Assay Kit (Thermo Fisher Scientific).
Lactate dehydrogenase and potassium leakage
Lactate dehydrogenase leakage from cells was measured in cell supernatants using a Lactate
Dehydrogenase Activity Assay Kit (Cambridge Bioscience) [6, 63]. Where indicated in Results,
LDH leakage from cells was normalized to the cellular DNA in the control challenge.
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To examine potassium leakage, 7.5 × 105 cells were seeded in 75 cm2 culture flasks in com-
plete media for 24 h, before treatment with or without 2 mM glutamine for a further 24 h in
serum-free media. Media were then discarded and cells washed three times with potassium-free
choline buffer (129 mM choline-Cl, 0.8 mM MgCl2, 1.5 mM CaCl2, 5 mM citric acid, 5.6 mM
glucose, 10 mM NH4Cl, 5 mM H3PO4, pH 7.4; all Sigma). Cells were then incubated in choline-
buffer with control medium or pyolysin for 5 min at 37˚C. Subsequently, cells were washed three
times in ice-cold choline-buffer and lysed in 0.5% Triton X-100 (Sigma) in double-distilled
water for 20 min at room temperature with gentle agitation. Potassium was measured in the
cleared lysates using a Jenway PFP7 flame photometer (Cole-Parmer, Stone, Staffordshire, UK).
Cholesterol assay
The bovine endometrial stromal cells and HeLa cells were grown at a density of 105 cells/well
in 12-well tissue culture plates for 24 h in complete media, and then cultured for 24 h in
serum-free media with or without 2 mM glutamine, or 0.5 mM methyl-β-cyclodextrin, as
described in Results. After the treatment period, cells were collected in 200 μl/well cholesterol
assay buffer (Thermo Fisher Scientific) and stored in Eppendorf tubes at -20˚C. When needed,
samples were defrosted at room temperature and sonicated for 10 min in a sonicating water
bath. Cellular cholesterol content was measured using the Amplex1 Red Cholesterol Assay
Kit (Thermo Fisher Scientific). Total cellular phospholipid was measured in the samples pre-
pared for the cholesterol assay using a phospholipid assay kit (MAK122, Sigma). Cholesterol
concentrations were then normalized to phospholipid concentrations.
Immunofluorescence
To examine actin distribution, cells were seeded at a 5 x 104 cells on glass coverslips in a 24-well
plate in complete medium for 24 h, followed by a further 24 h in serum-free medium with or with-
out 2 mM glutamine. Cells were challenged for 2 h with the corresponding control medium or
medium containing pyolysin, as specified in Results. Cells were washed with PBS, fixed with 4%
paraformaldehyde, washed in PBS and then permeabilized in 0.2% Triton X-100. Cells were then
blocked using 0.5% bovine serum albumin and 0.1% Triton X-100 in PBS, followed by incubation
with Alexa Fluor 555-conjugated phalloidin (Thermo Fisher Scientific). Cells were washed in 0.1%
Triton X-100 in PBS three times and mounted onto microscope slides, using 40,6-diamidino-2-phe-
nylindole (Vectashield with DAPI; Vector Laboratories Inc., Burlington, CA, USA) to visualize cell
nuclei. Cell morphology and target localization were analyzed with an Axio Imager M1 upright
fluorescence microscope (Zeiss, Jena, Germany) and images captured using an AxioCamMR3.
To image cholesterol, 5 x 104 cells were seeded on glass coverslips in a 24 well plate in com-
plete medium for 24 h, followed by 24 h in serum-free medium with or without L-glutamine,
or 0.5 mM methyl-β-cyclodextrin, as described in Results. Coverslips were washed with PBS,
fixed with 4% paraformaldehyde, and washed with PBS. Coverslips were then incubated for 45
min at room temperature with 50 μg/ml filipin III from Streptomyces filipinensis (Sigma). Cells
were washed with PBS before being mounted using 2.5% Mowiol mounting medium contain-
ing 2.5% DABCO (1,4-diazabicyclo-(2,2,2)-octane, Merck). Cell cholesterol was analyzed
using a LSM710 confocal microscope (Zeiss) with the Zeiss Zen 2010 software. Images were
captured using a 40x oil objective and a 410–476 nm channel range; coverslips were subjected
to identical exposure times and conditions.
Statistical analysis
Data are presented as arithmetic mean and error bars represent SEM. The statistical unit was
each animal used to isolate bovine endometrial stromal cells or each independent passage of
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HeLa cells. Statistical analysis was performed using SPSS 22.0 (SPSS Inc. Chicago, IL), and
P< 0.05 was considered significant. Comparisons were made between treatments using one-
way or two-way ANOVA with two-tailed Bonferroni or Dunnett’s posthoc test, or unpaired
two-tailed Student’s t test, as specified in Results and figure legends.
Supporting information
S1 Fig. Similar cell growth curves irrespective of glutamine supply for HeLa cells cultured
with serum. HeLa cells were cultured in medium containing 10% fetal calf serum and 2 mM
glutamine for 24 h, and then with or without 2 mM glutamine for a further 72 h. Cell viability
was measured using the MTT assay every 24 h. The data are reported as mean (SEM) from 4
independent passages. Data were analyzed by 2-way ANOVA; there was a significant effect of
time (F(3, 24) = 113.6, P< 0.0001) but not for glutamine (F(1, 24) = 0.0005, P = 0.98) or the inter-
action of time x glutamine (F(3, 24) = 0.5, P = 0.71).
(PDF)
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